Skip to content
10-K

Annual Report

PROTALIX BIOTHERAPEUTICS, INC. PLX

0001104659-26-029858

← back to feed
Filed
Mar 18, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 1, 2026 80.57M sh
Shares Diluted FY 2025 · Dec 31, 2025 78.55M sh
Shares Diluted FY 2025 · Dec 31, 2024 81.06M sh
Shares Diluted FY 2025 · Dec 31, 2023 82.42M sh
Capex FY 2025 · Dec 31, 2025 $1.64M
Capex FY 2025 · Dec 31, 2024 $1.28M
Capex FY 2025 · Dec 31, 2023 $1.15M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$11.99M
Operating Cash Flow FY 2025 · Dec 31, 2024 $8.67M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$1.32M
Cash And Equivalents FY 2025 · Dec 31, 2025 $14.68M
Cash And Equivalents FY 2025 · Dec 31, 2024 $19.76M
Stockholders Equity FY 2025 · Dec 31, 2025 $48.23M
Stockholders Equity FY 2025 · Dec 31, 2024 $43.21M
Stockholders Equity FY 2025 · Dec 31, 2023 $33.57M
Stockholders Equity FY 2025 · Dec 31, 2022 −$10.64M
Current Liabilities FY 2025 · Dec 31, 2025 $26.52M
Current Liabilities FY 2025 · Dec 31, 2024 $25.62M
Total Liabilities FY 2025 · Dec 31, 2025 $34.12M
Total Liabilities FY 2025 · Dec 31, 2024 $30.21M
Current Assets FY 2025 · Dec 31, 2025 $66.67M
Current Assets FY 2025 · Dec 31, 2024 $60.08M
Total Assets FY 2025 · Dec 31, 2025 $82.35M
Total Assets FY 2025 · Dec 31, 2024 $73.42M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.08
Eps Diluted FY 2025 · Dec 31, 2024 $0.04
Eps Diluted FY 2025 · Dec 31, 2023 $0.09
Eps Basic FY 2025 · Dec 31, 2025 −$0.08
Eps Basic FY 2025 · Dec 31, 2024 $0.04
Eps Basic FY 2025 · Dec 31, 2023 $0.12
Sga Expense FY 2025 · Dec 31, 2025 $11.68M
Sga Expense FY 2025 · Dec 31, 2024 $12.19M
Sga Expense FY 2025 · Dec 31, 2023 $14.96M
Rd Expense FY 2025 · Dec 31, 2025 $19.57M
Rd Expense FY 2025 · Dec 31, 2024 $12.97M
Rd Expense FY 2025 · Dec 31, 2023 $17.09M
Net Income FY 2025 · Dec 31, 2025 −$6.6M
Net Income FY 2025 · Dec 31, 2024 $2.93M
Net Income FY 2025 · Dec 31, 2023 $8.31M
Operating Income FY 2025 · Dec 31, 2025 −$5.5M
Operating Income FY 2025 · Dec 31, 2024 $3.92M
Operating Income FY 2025 · Dec 31, 2023 $10.46M
Cost Of Revenue FY 2025 · Dec 31, 2025 $26.99M
Cost Of Revenue FY 2025 · Dec 31, 2024 $24.32M
Cost Of Revenue FY 2025 · Dec 31, 2023 $22.98M
Revenue FY 2025 · Dec 31, 2025 $52.74M
Revenue FY 2025 · Dec 31, 2024 $53.4M
Revenue FY 2025 · Dec 31, 2023 $65.49M